PODATKI IN VITRO in English translation

• in vitro data

Examples of using Podatki in vitro in Slovenian and their translations into English

Glede na podatke in vitro je znano, da sta riociguat in njegov glavni presnovek substrata prenašalnih proteinov P-gp(P-glikoprotein) in BCRP(protein odpornosti na raka dojke).
Based on in vitro data riociguat and its main metabolite are substrates of the transporter proteins P-gp(P-glycoprotein) and BCRP(breast cancer resistance protein).

Na podlagi podatkov in vitro ni pričakovati klinično pomembnega medsebojnega delovanja zdravila ZEPATIER
Based on in vitro data, clinically significant interactions with ZEPATIER as an inhibitor of other CYP enzymes,

Na podlagi podatkov in vitro cinakalcet močno zavira CYP2D6,
Based on in vitro data, cinacalcet is a strong inhibitor of CYP2D6,

Podatke in vitro lahko uporabite za delno ali polno izpolnjevanje zahtev po informacijah, za katere bi se podatki v nasprotnem primeru morali pridobiti s testi na živih organizmih(testi in vivo).
You can use in vitro data to fully or partly fulfil information requirements that would otherwise need data to be generated with tests on living organisms(in vivo tests).

Na podlagi podatkov in vitro in/ali izkušenj iz kliničnih preskušanj je mogoče pričakovati,
Based upon in-vitro data and/or clinical trial experience, the organisms associated

Na podlagi podatkov in vitro ni mogoče izključiti inhibicije BCRP
Based on in vitro data, inhibition of BCRP and MRP2(in the intestine),

Podatki in vitro.
In vitro data.

Podatki in vitro kažejo tudi indukcijo CYP2C19.
In vitro data also suggest an induction of CYP2C19.

Podatki in vitro kažejo, da je kabozantinib substrat MRP2.
In vitro data demonstrate that cabozantinib is a substrate of MRP2.

Podatki in vitro kažejo, da je netupitant zaviralec P-gp.
In vitro data show that netupitant is a P-gp inhibitor.

Podatki in vitro kažejo, da ima brivaracetam nizek interakcijski potencial.
In vitro data suggest that brivaracetam has a low interaction potential.

Podatki in vitro kažejo, da se cinakalcet deloma presnavlja s CYP1A2.
In vitro data indicate that cinacalcet is in part metabolised by CYP1A2.

Podatki in vitro kažejo, da naslednje vrste niso občutljive za ceftarolin.
In vitro data indicate that the following species are not susceptible to ceftaroline.

Podatki in vitro so pokazali rahlo zvečanje odpornosti C. glabrata na vorikonazol.
In vitro data showed a slight increase of resistance of C. glabrata to voriconazole.

Podatki in vitro kažejo, da je gefitinib substrat membranske transportne beljakovine Pgp.
In vitro data indicate that gefitinib is a substrate for the membrane transport protein Pgp.

Podatki in vitro kažejo, da enzalutamid morda zavira efluksni prenašalec P -gp.
In vitro data indicate that enzalutamide may be an inhibitor of the efflux transporter P-gp.

Podatki in vitro kažejo, da CYP2D6
In vitro data indicate that CYP2D6

Podatki in vitro nakazujejo, da netupitant zavira prehod prenašalca BCRP skozi membrane.
In vitro data suggests that netupitant inhibits the efflux of transporter BCRP.

Podatki in vitro kažejo, da sitagliptin ne zavira in ne inducira izoencimov CYP450.
In vitro data suggest that sitagliptin does not inhibit nor induce CYP450 isoenzymes.

Podatki in vitro kažejo, da je paritaprevir substrat humanih jetrnih privzemnih prenašalcev OATP1B1 in OATP1B3.
In vitro data indicate that paritaprevir is a substrate for the human hepatic uptake transporters, OATP1B1 and OATP1B3.